Details for New Drug Application (NDA): 018297
✉ Email this page to a colleague
The generic ingredient in LOPURIN is allopurinol. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the allopurinol profile page.
Summary for 018297
Tradename: | LOPURIN |
Applicant: | Abbott |
Ingredient: | allopurinol |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018297
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018297
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | LOPURIN | allopurinol | TABLET;ORAL | 018297-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | LOPURIN | allopurinol | TABLET;ORAL | 018297-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription